Clinical Trial Update: Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for FS-8002 in advanced solid tumors. The study assesses safety, tolerability, pharmacokinetics, and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• FS-8002

Snippet

Sponsor: Shanghai Pushi Medical Science Co. Ltd | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING